Ke receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease.

From LinkbotLabs
Jump to: navigation, search

Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA Jr: Tumor Ere with RV replication. Piclamilast didn't alter the virion quantity necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Trian T, Burgess JK, Niimi K, Moir LM, Ge Q, Berger P, Liggett SB, Black JL, Oliver BG: Beta2-agonist induced cAMP is decreased in asthmatic airway smooth muscle resulting from increased PDE4D. PLoS A single 2011, six:e20000. 23. Grootendorst DC, Gauw SA, Verhoosel RM, Sterk PJ, Hospers JJ, Bredenbr er D, Bethke TD, Hiemstra PS, Rabe KF: Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in pat.Ke receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease. Biochem Soc Trans 2007, 35:1492?495. 7. Hewson CA, Jardine A, Edwards MR, Laza-Stanca V, Johnston SL: Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005, 79:12273. eight. Slater L, Bartlett NW, Haas JJ, Zhu J, Message SD, Walton RP, Sykes A, Dahdaleh S, Clarke DL, Belvisi MG, et al: Co-ordinated function of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010, six:e1001178. 9. Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, Meyer J, title= fnins.2013.00251 Lackie PM, Sanderson G, Holgate ST, Johnston SL: Rhinoviruses infect the lower airways. J Infect Dis 2000, 181:1875?884. 10. Oliver B, Johnston S, Baraket M, Burgess J, King N, Roth M, Lim S, Black J: Improved proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir Res 2006, 7:71. 11. Van Ly D, Faiz A, Jenkins C, Crossett B, Black JL, McParland B, Burgess JK, Oliver BG: Characterising the mechanism of airway smooth muscle beta2 adrenoceptor desensitization by rhinovirus infected bronchial epithelial cells. PLoS 1 2013, eight:e56058. 12. Black JL, Panettieri RA Jr, Banerjee A, Berger P: Airway smooth muscle in asthma: just a target for bronchodilation? Clin Chest Med 2012, 33:543?58. 13. Panettieri RA Jr: Airway smooth muscle: immunomodulatory cells? Allergy Asthma Proc 2004, 25:381?86. 14. Daniel PB, Walker WH, Habener JF: Cyclic AMP signaling and gene regulation. Annu Rev Nutr 1998, 18:353?83. 15. Strandberg K, Palmberg L, Larsson K: Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells. Respir Med 2007, 101:1132?139. 16. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA Jr: Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 2002, 26:465?74. 17. Wu YL, Wiltbank MC: Transcriptional regulation in the cyclooxygenase-2 gene alterations from protein kinase (PK) a- to PKC-dependence right after luteinization of granulosa cells. Biol Reprod 2002, 66:1505?514. 18. Billington CK, Pascual RM, Hawkins ML, Penn RB, Hall IP: Interleukin-1beta and rhinovirus sensitize adenylyl cyclase in human airway smoothmuscle cells. Am J Respir Cell Mol Biol title= journal.pone.0111391 2001, 24:633?39.19. Edwards MR, Haas J, Panettieri RA Jr, Johnson M, Johnston SL: Corticosteroids and beta2 agonists differentially regulate rhinovirusinduced interleukin-6 through distinct Cis-acting components.